Thrivent Financial for Lutherans Decreases Stock Position in R1 RCM Inc. (NASDAQ:RCM)

Thrivent Financial for Lutherans lessened its holdings in R1 RCM Inc. (NASDAQ:RCM) by 3.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,838 shares of the healthcare provider’s stock after selling 1,549 shares during the period. Thrivent Financial for Lutherans’ holdings in R1 RCM were worth $601,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Sei Investments Co. lifted its stake in shares of R1 RCM by 212.5% during the second quarter. Sei Investments Co. now owns 37,612 shares of the healthcare provider’s stock valued at $472,000 after buying an additional 25,576 shares during the period. King Luther Capital Management Corp lifted its stake in shares of R1 RCM by 0.9% during the 2nd quarter. King Luther Capital Management Corp now owns 819,858 shares of the healthcare provider’s stock worth $10,297,000 after purchasing an additional 7,413 shares during the period. XTX Topco Ltd lifted its stake in shares of R1 RCM by 13.0% during the 2nd quarter. XTX Topco Ltd now owns 46,197 shares of the healthcare provider’s stock worth $580,000 after purchasing an additional 5,306 shares during the period. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of R1 RCM by 46.3% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 15,946 shares of the healthcare provider’s stock worth $200,000 after purchasing an additional 5,049 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of R1 RCM by 4.5% in the second quarter. Dimensional Fund Advisors LP now owns 3,154,888 shares of the healthcare provider’s stock valued at $39,624,000 after purchasing an additional 136,808 shares during the period. 61.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Morgan Stanley lowered R1 RCM from an “overweight” rating to an “equal weight” rating in a research note on Thursday, August 8th. Truist Financial lowered their target price on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating for the company in a report on Thursday, August 8th. Leerink Partnrs downgraded shares of R1 RCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Cantor Fitzgerald reiterated a “neutral” rating and issued a $14.30 price target on shares of R1 RCM in a report on Friday, October 4th. Finally, Robert W. Baird reissued an “outperform” rating and set a $18.00 price target on shares of R1 RCM in a research report on Tuesday, July 2nd. Thirteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $15.41.

R1 RCM Stock Up 0.1 %

Shares of NASDAQ:RCM opened at $14.21 on Wednesday. R1 RCM Inc. has a 12-month low of $8.87 and a 12-month high of $15.12. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.99 billion, a PE ratio of -177.63 and a beta of 0.85. The company has a fifty day simple moving average of $14.06 and a 200 day simple moving average of $13.05.

R1 RCM (NASDAQ:RCM) last posted its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. R1 RCM had a negative return on equity of 1.44% and a negative net margin of 1.68%. The business had revenue of $627.90 million during the quarter, compared to the consensus estimate of $633.10 million. R1 RCM’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, equities research analysts anticipate that R1 RCM Inc. will post -0.24 EPS for the current fiscal year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.